MedTrace Logo

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

NCT00555633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2009-09-30

No results posted yet for this study

Summary

Study aim: To determine the effect of an intensified daily photoprotection over 24 months with an SPF30 sunscreen and an after sun-lotion both containing liposomal DNA repair enzymes in a population of patients at high-risk for skin cancer, including xeroderma pigmentosum (XP) and basal cell nevus syndrome.

Conditions

  • Skin Cancer
  • Xeroderma Pigmentosum
  • Basal Cell Nevus Syndrome

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Peter Wolf, MD · Medical University of Graz, Austria

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2006-02-28

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00555633 on ClinicalTrials.gov